NCT05143372 is a NA clinical trial of Vibrolung in COVID-19, sponsored by Astana Medical University.

Who is sponsoring NCT05143372?

NCT05143372 is sponsored by Astana Medical University.

What drugs are being tested in NCT05143372?

Interventions in NCT05143372: Vibrolung.

What condition does NCT05143372 study?

NCT05143372 studies COVID-19, Acute Respiratory Failure, Vibration; Exposure.

Is NCT05143372 still recruiting?

NCT05143372 is currently completed. Last updated 12 February 2024.

Last reviewed 2024-02-12 · How we verify

NCT05143372

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Vibroacoustic Therapy Modes on the Course of Coronavirus Infection

Completed NA Last updated 12 February 2024

What this trial tests

NA trial testing Vibrolung in COVID-19 in 60 participants. Completed in 30 September 2023.

Timeline

9 November 2021

Primary endpoint
30 September 2023

30 September 2023

Quick facts

Lead sponsor	Astana Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	9 November 2021
Primary completion	30 September 2023
Estimated completion	30 September 2023
Sites	3 locations across Kazakhstan

Drugs / interventions tested

Vibrolung

Conditions studied

COVID-19 — all drugs for COVID-19 →
Acute Respiratory Failure — all drugs for Acute Respiratory Failure →
Vibration; Exposure — all drugs for Vibration; Exposure →

Sponsor

Astana Medical University

Who can join

18 and older, any sex, with COVID-19 or Acute Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment of the dynamics of changes in physical, instrumental and laboratory parameters in patients with identified coronavirus infection complicated by acute respiratory failure included in the study in accordance with the inclusion criteria, and comparison of the results with the control group, study of the effect of modes when using vibroacoustic lung therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Vibroacoustic therapy in the treatment of patients with COVID-19 complicated by respiratory failure: a pilot randomized controlled trial.
Konkayev A, Bekniyazova A. · · 2023 · PMID 38155668 · DOI 10.3389/fmed.2023.1225384

Verify or expand the search:

Other trials of Vibrolung

Trials testing the same drug.

NCT07517497 — The Course of Acute Respiratory Failure in Geriatric Patients With Hip Fracture Using Different Modes of a Vibroacoustic · NA · recruiting
NCT03911947 — Evaluation of the Effectiveness of Vibroacoustic Therapy in the Complex Treatment of Acute Respiratory Failure · NA · completed

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Astana Medical University trials

Trials by the same sponsor.

NCT07038213 — Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients Wit · enrolling by invitation
NCT07517497 — The Course of Acute Respiratory Failure in Geriatric Patients With Hip Fracture Using Different Modes of a Vibroacoustic · NA · recruiting
NCT05693428 — Influence of Anesthetics on Clinical Outcome During Cardiac Surgery in Adults · NA · completed
NCT05742789 — Effect of Anesthetics on Troponin I and С-reactive Protein · Phase 1 · completed
NCT05695287 — The Effects of Sevoflurane, Isoflurane and Propofol During Cardiac Surgery · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05143372 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Astana Medical University
Last refreshed: 12 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05143372.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing